Off-Target Serine/Threonine Kinase 10 Inhibition by Erlotinib Enhances Lymphocytic Activity Leading to Severe Skin Disorders

Title
Off-Target Serine/Threonine Kinase 10 Inhibition by Erlotinib Enhances Lymphocytic Activity Leading to Severe Skin Disorders
Authors
Keywords
-
Journal
MOLECULAR PHARMACOLOGY
Volume 80, Issue 3, Pages 466-475
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Online
2011-05-24
DOI
10.1124/mol.110.070862

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now